These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25774821)

  • 41. Impact of age on quality-of-life outcomes after treatment for localized prostate cancer.
    Hampson LA; Cowan JE; Zhao S; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Sep; 68(3):480-6. PubMed ID: 25656807
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radical prostatectomy versus brachytherapy for clinically localized prostate cancer on oncological and functional outcomes: a meta-analysis.
    Zhang P; Qian B; Shi J; Xiao Y
    Transl Androl Urol; 2020 Apr; 9(2):332-343. PubMed ID: 32420139
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brachytherapy versus prostatectomy in localized prostate cancer: results of a French multicenter prospective medico-economic study.
    Buron C; Le Vu B; Cosset JM; Pommier P; Peiffert D; Delannes M; Flam T; Guerif S; Salem N; Chauveinc L; Livartowski A
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):812-22. PubMed ID: 17293235
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quality of life outcomes after brachytherapy for early stage prostate cancer.
    Brandeis JM; Litwin MS; Burnison CM; Reiter RE
    J Urol; 2000 Mar; 163(3):851-7. PubMed ID: 10687991
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Health-related quality of life after radical retropubic prostatectomy and permanent prostate brachytherapy: a 3-year follow-up study.
    Hashine K; Yuasa A; Shinomori K; Ninomiya I; Kataoka M; Yamashita N
    Int J Urol; 2011 Dec; 18(12):813-9. PubMed ID: 21995507
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term toxicity and quality of life up to 10 years after low-dose rate brachytherapy for prostate cancer.
    Emara AM; Chadwick E; Nobes JP; Abdelbaky AM; Laing RW; Langley SE
    BJU Int; 2012 Apr; 109(7):994-1000. PubMed ID: 21854533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sexual function with localized prostate cancer: active surveillance vs radical therapy.
    van den Bergh RC; Korfage IJ; Roobol MJ; Bangma CH; de Koning HJ; Steyerberg EW; Essink-Bot ML
    BJU Int; 2012 Oct; 110(7):1032-9. PubMed ID: 22260273
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prospective evaluation of short-term impact and recovery of health related quality of life in men undergoing robotic assisted laparoscopic radical prostatectomy versus open radical prostatectomy.
    Miller J; Smith A; Kouba E; Wallen E; Pruthi RS
    J Urol; 2007 Sep; 178(3 Pt 1):854-8; discussion 859. PubMed ID: 17631338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
    Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Direct Comparison of Two Different Definitions with Biochemical Recurrence after Low-Dose-Rate Brachytherapy for Prostate Cancer.
    Takeuchi S; Iinuma K; Nakane K; Nakano M; Kawase M; Kawase K; Takai M; Kato D; Mori T; Takano H; Kumano T; Matsuo M; Koie T
    Curr Oncol; 2023 Feb; 30(3):2792-2800. PubMed ID: 36975425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
    Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA
    J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A 3-y prospective study of health-related and disease-specific quality of life in patients with nonmetastatic prostate cancer treated with radical prostatectomy or external beam radiotherapy.
    Yoshimura K; Arai Y; Ichioka K; Matsui Y; Ogura K; Terai A
    Prostate Cancer Prostatic Dis; 2004; 7(2):144-51. PubMed ID: 15111981
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Men with low preoperative sexual function may benefit from nerve sparing radical prostatectomy.
    Harris CR; Punnen S; Carroll PR
    J Urol; 2013 Sep; 190(3):981-6. PubMed ID: 23410984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patterns of recurrence after low-dose-rate prostate brachytherapy: a population-based study of 2223 consecutive low- and intermediate-risk patients.
    Lo AC; Morris WJ; Pickles T; Keyes M; McKenzie M; Tyldesley S
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):745-51. PubMed ID: 25752387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer.
    Hashine K; Kusuhara Y; Miura N; Shirato A; Sumiyoshi Y; Kataoka M
    Jpn J Clin Oncol; 2008 Jul; 38(7):480-5. PubMed ID: 18621847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Economic evaluation of treatments for patients with localized prostate cancer in Europe: a systematic review.
    Becerra V; Ávila M; Jimenez J; Cortes-Sanabria L; Pardo Y; Garin O; Pont A; Alonso J; Cots F; Ferrer M;
    BMC Health Serv Res; 2016 Oct; 16(1):541. PubMed ID: 27716267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer.
    Malcolm JB; Fabrizio MD; Barone BB; Given RW; Lance RS; Lynch DF; Davis JW; Shaves ME; Schellhammer PF
    J Urol; 2010 May; 183(5):1822-8. PubMed ID: 20303100
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Systematic Review of Clinical Trials Comparing Radiation Therapy Versus Radical Prostatectomy in Prostate Cancer.
    Hekman L; Barrett A; Ross D; Palaganas E; Giridhar P; Elumalai T; V P; Block AM; Welsh JS; Harkenrider MM; Saini S; Roy S; Farooq A; Gupta G; Hsieh CE; Venkatesulu B; Solanki AA
    Clin Genitourin Cancer; 2024 Oct; 22(5):102157. PubMed ID: 39084158
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of Long-term Changes in Lower Urinary Tract Symptoms in Patients With Prostate Cancer Who Underwent Low-dose-rate Prostate Brachytherapy.
    Iinuma K; Nakano M; Kato T; Kato D; Takai M; Maekawa YM; Nakane K; Mizutani K; Tsuchiya T; Ishihara T; Ito M; Matsuo M; Koie T
    Urology; 2020 Aug; 142():213-220. PubMed ID: 32416115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control.
    Hu JC; Gandaglia G; Karakiewicz PI; Nguyen PL; Trinh QD; Shih YC; Abdollah F; Chamie K; Wright JL; Ganz PA; Sun M
    Eur Urol; 2014 Oct; 66(4):666-72. PubMed ID: 24602934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.